Ted W Love's Net Worth
$45.2 Million
Who is Ted W Love?
Ted W Love has an estimated net worth of $45.2 Million. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, Oncothyreon Inc., Royalty Pharma plc, BIO RAD LABORATORIES INC, Structure Therapeutics Inc., AMICUS THERAPEUTICS INC, Global Blood Therapeutics, Inc., KALOBIOS PHARMACEUTICALS INC, ADVENTRX PHARMACEUTICALS INC, NUVELO INC, AFFYMAX INC, SANTARUS INC, ONYX PHARMACEUTICALS INC, PORTOLA PHARMACEUTICALS INC, and GILEAD SCIENCES, INC..
SEC CIK
Ted W Love's CIK is 0001188919
Past Insider Trading and Trends
2012 was Ted W Love's most active year for acquiring shares with 14 total transactions. Ted W Love's most active month to acquire stocks was the month of May. 2022 was Ted W Love's most active year for disposing of shares, totalling 28 transactions. Ted W Love's most active month to dispose stocks was the month of July. 2012 saw Ted W Love paying a total of $2,332,575.00 for 521,716 shares, this is the most they've acquired in one year. In 2014 Ted W Love cashed out on 573,000 shares for a total of $16,547,365.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Seagen Inc. (SGEN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.25K |
$229.00 | -$974,395.00 |
0
|
Dec 14
| |||
Form 4
| +43.45% | 2.04K |
—
|
—
| 6.75K |
May 31
| |||
Form 4
| +46.95% | 1.5K |
—
|
—
| 4.7K |
May 13
| |||
Form 4
| +77.93% | 1.4K |
—
|
—
| 3.2K |
May 14
| |||
Form 4
|
∞
| 1.8K |
—
|
—
| 1.8K |
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cascadian Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -37.39K |
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +5.00% | 1.78K |
$3.94 | -$2,340.36 | 37.39K |
Sep 24
| |||
Form 4
| +23.57% | 6.79K |
$3.78 | -$8,561.70 | 35.61K |
Jun 24
| |||
Form 4
| +5.92% | 1.61K |
$3.34 | -$1,793.58 | 28.82K |
Jun 9 - Jun 12
| |||
Form 4
| +546.45% | 23K |
$4.24 | $97,520.00 | 27.21K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 4
|
∞
| 13.01K |
$3.25 | -$14,092.00 | 13.01K |
Sep 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Royalty Pharma plc (RPRX) Snapshot price: $28.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.16% | 9.29K |
—
|
—
| 46.23K |
Jun 7
| |||
Form 4
| +26.54% | 7.75K |
—
|
—
| 36.94K |
Jun 23
| |||
Form 4
| +27.67% | 6.33K |
—
|
—
| 29.19K |
Jun 24
| |||
Form 4
| +33.41% | 5.73K |
—
|
—
| 22.87K |
Jun 25
| |||
Form 4
| +72.80% | 7.28K |
—
|
—
| 17.28K |
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIO RAD LABORATORIES INC (BIO) Snapshot price: $329.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Structure Therapeutics Inc. (GPCR) Snapshot price: $36.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |